STIM

STIM
Lisa-Rut · CC BY-SA 4.0 · source
Name	STIM
Caption	STIM schematic
Organisms	Vertebrates

STIM

STIM is a family of transmembrane signaling proteins involved in calcium sensing and store-operated calcium entry. First characterized in vertebrate cell signaling, STIM proteins link intracellular calcium depletion to activation of plasma membrane calcium channels. STIM homologs play roles across multicellular organisms and intersect with numerous signaling pathways described in studies of Nobel Prize in Physiology or Medicine, Howard Hughes Medical Institute, National Institutes of Health, Max Planck Society laboratories and academic groups at institutions such as Harvard University and University of Cambridge.

Introduction

STIM proteins are single-pass transmembrane proteins localized predominantly to the endoplasmic reticulum membrane and are central regulators of store-operated calcium entry (SOCE). Key elements of STIM function were elucidated in collaborations among groups at University of California, Berkeley, Imperial College London, University of Pennsylvania, Stanford University School of Medicine and researchers funded by European Research Council and Wellcome Trust. STIM proteins detect decreases in luminal calcium via conserved EF-hand domains and undergo conformational changes that enable interactions with plasma membrane calcium channels such as ORAI and TRPC family members. Studies linking STIM to physiological systems involve model organisms including Mus musculus, Danio rerio, Drosophila melanogaster and Caenorhabditis elegans.

History

The discovery and naming of STIM arose from genetic and proteomic screens in the early 2000s conducted at labs affiliated with Yale University, University of Texas Southwestern Medical Center, Columbia University, and Karolinska Institutet. Initial reports connected STIM to calcium signaling in lymphocytes studied in contexts related to the Janeway Immunobiology-influenced research tradition and immune deficiency phenotypes described in clinical centers such as Mayo Clinic and Cleveland Clinic. Subsequent structural studies at facilities including European Molecular Biology Laboratory and Rutherford Appleton Laboratory revealed EF-hand and sterile alpha motif (SAM) domains, while cryo-electron microscopy projects led by teams at Massachusetts Institute of Technology and California Institute of Technology refined models of STIM oligomerization. The role of STIM in human disease became evident through collaborations between university hospitals such as Johns Hopkins Hospital and genetic consortia like 1000 Genomes Project.

Structure and Function

STIM proteins possess an N-terminal luminal region containing an EF-hand calcium-binding motif and a SAM domain, a single transmembrane helix, and a large cytosolic tail with coiled-coil regions and a polybasic domain. Structural investigations have been published by groups at Max Planck Institute for Biophysical Chemistry, Scripps Research, University of Oxford and biotech laboratories associated with GlaxoSmithKline and Pfizer. Upon depletion of endoplasmic reticulum calcium stores—mechanistically linked in studies with inositol 1,4,5-trisphosphate receptors characterized at Rosetta Genomics-era labs—EF-hand unbinding triggers STIM oligomerization and translocation to endoplasmic reticulum–plasma membrane junctions. There, STIM engages plasma membrane channels like ORAI1, identified in genetic studies at Children's Hospital of Philadelphia, and interacts with TRPC1 channels described in reports from University of Milan and University of California, San Diego. The STIM–ORAI interaction drives calcium influx critical for processes studied by investigators at Rockefeller University, Duke University, University of Michigan, and Yale School of Medicine.

STIM isoforms, including STIM1 and STIM2, show different activation thresholds and kinetics; STIM1 is prominent in rapid SOCE, while STIM2 contributes to maintaining basal calcium levels, as demonstrated in comparative work from University College London and National Center for Biotechnology Information-linked projects. Post-translational modifications such as phosphorylation and ubiquitination, investigated by teams at ETH Zurich and Weizmann Institute of Science, modulate STIM localization and turnover.

Clinical Significance and Disorders

Mutations and dysregulation of STIM proteins are implicated in immunodeficiency, myopathy, thrombocytopenia and neurodegenerative conditions. Loss-of-function variants in ORAI1–STIM pathways correlate with severe combined immunodeficiency-like phenotypes documented by clinicians at Boston Children's Hospital and Great Ormond Street Hospital. Aberrant STIM signaling is associated with cardiac hypertrophy and arrhythmia in studies from Mayo Clinic and Cleveland Clinic Foundation Heart Center, as well as with cancer cell proliferation and metastasis investigated at National Cancer Institute, Memorial Sloan Kettering Cancer Center and Dana-Farber Cancer Institute. Neurodegenerative links have been explored in research at University of Toronto and University of Sydney focusing on calcium homeostasis in neurons. Diagnostic and genetic counseling efforts for STIM-related disorders involve centers such as Genomics England and consortia including ClinGen.

Research and Therapeutic Applications

Research on STIM spans basic structural biology, physiology, pharmacology and translational medicine. High-throughput screens conducted at Broad Institute and Novartis Institutes for BioMedical Research seek small molecules that modulate STIM–ORAI interactions. Gene-editing approaches using CRISPR-Cas9 in model systems at Broad Institute and Karolinska Institutet aim to model pathogenic variants. Therapeutic strategies under investigation include peptides that disrupt STIM clustering, small-molecule inhibitors of ORAI channels tested at pharmaceutical companies such as AstraZeneca and Eli Lilly and Company, and antisense oligonucleotides developed in programs affiliated with Ionis Pharmaceuticals. Clinical trials facilitated by networks including ClinicalTrials.gov and cooperative groups at European Medicines Agency-partner institutions evaluate safety and efficacy in immune and muscular disorders. Ongoing collaborations among academic medical centers such as UCSF Medical Center, Mount Sinai Health System, and industry partners continue to translate STIM biology into potential interventions.

Category:Proteins